Thank you! Your submission was successful. We will contact you shortly.
For some reason submission was unsuccessful. Please, contact us directly at vetinel@allegene.com
FAQs
Find answers to the most common questions about our veterinary treatments, services, and pet care. Our FAQ section is designed to help you make informed decisions about your animal's health.
Veterinarians
What is Vetinel® CellTech?
Vetinel® CellTech is a veterinary autologous biologics platform built on Allegene Pharmalabs’ human regenerative medicine heritage. It delivers GEN4™ closed-system consumables and workflows for consistent, point-of-care biologic preparation across species
What does “GEN4™” mean in practice?
GEN4™ represents fourth-generation biologics: fully closed systems, human-grade materials, validated centrifugation, and reproducible cellular yields—without silica, gels, or filtration artifacts.
What biologics can be prepared withVetinelsystems?
Platelet-rich concentrates (CTR™/PRP), peripheral blood stem cell–enriched fractions, bone marrow–derived concentrates (BMAC), and adipose-derived cellular fractions—depending on protocol and indication.
Are stem cells involved?
Yes. Certain Vetinel protocols enable safe point-of-care preparation of stem-cell–containing fractions (e.g. MSC-rich BMAC or adipose-derived cells), using the animal’s own tissue.
Is this compliant with field and clinic use?
GEN4™ systems are designed specifically for veterinary point-of-care use, with 100% closed processing, gamma-sterilized consumables, and workflows validated for stable, clinic, and mobile environments.
How consistent are the outcomes?
Consistency is engineered. GEN4™ systems deliver validated platelet concentration ranges, high cellular viability (>96%), and repeatable biologic quality—minimizing operator and environment variability.
Which species are supported?
Protocols are adapted and validated for equines, camelids, and companion animals, with scalable volumes and species-specific workflows.
How does Vetinel differ from standard PRP kits?
Unlike generic PRP kits, Vetinel GEN4™ systems are true concentrating platforms—human-grade, closed, filtration-free, and designed to meet regenerative thresholds rather than diluted approximations.
Owners
What is Vetinel in simple terms?
Vetinel helps veterinarians use your animal’s own cells to support natural healing—right at the clinic or stable, without sending samples to a lab.
What kinds of problems can this help with?
Common uses include joint issues, tendon and ligament injuries, wounds, mobility problems, and age-related degeneration—depending on your veterinarian’s diagnosis.
Does this involve drugs or foreign substances?
No. Vetinel therapies are autologous, meaning they are made from your animal’s own blood or tissue, reducing the risk of rejection or incompatibility.
Is it safe for my animal?
Safety is central. Vetinel systems use hospital-grade materials and fully closed sterile processes, designed specifically for veterinary care.
Will this cure my animal?
These therapies are not “miracle cures.” They are regenerative tools that support the body’s natural repair processes and may improve comfort, function, and quality of life.
How quickly does treatment happen?
In many cases, biologics are prepared and used during the same visit—without delays, shipping, or additional stress for your animal.
Is this only for horses?
No. Vetinel solutions are used for horses, camels, dogs, and other companion animals, with protocols adapted to size and species.
How do I know if this is right for my animal?
Your veterinarian is the best person to advise. Vetinel provides the platform; clinical decisions remain with the treating professional.
Riders
Why is Vetinel speaking directly to riders?
Because in professional racing, performance is shared. The health of the animal and the health of the rider are inseparable. Vetinel supports the animal through veterinary biologics, while Allegene Pharmalabs supports the rider through human autologous biologics—treating both sides of the same athletic system.
What is Allegene Pharmalabs’ role for riders?
Allegene Pharmalabs develops human-grade autologous biologics under its ámvyx® platform, designed to support tissue repair, recovery, and durability in professional athletes—including riders exposed to repetitive stress, impact, and injury.
What kinds of rider injuries or conditions can be addressed?
Human autologous biologics are commonly used to support recovery from: • Joint degeneration and overload (knees, hips, spine) • Tendon and ligament injuries • Muscle strains and soft-tissue trauma • Chronic inflammation from repetitive impact • Skin and tissue damage related to sun exposure and environmental stress Treatment decisions are always made by qualified medical professionals.
What does “autologous biologics” mean for me as a rider?
It means therapies prepared from your own biological material, such as blood or tissue, and used to support your body’s natural repair mechanisms—without foreign substances or donor material.
How is this different from standard sports medicine treatments?
Autologous biologics aim to address tissue quality and recovery at a biological level, rather than only masking symptoms. When appropriately indicated, they may complement rehabilitation, physiotherapy, and training programs
Is this only for injured riders, or also for long-term wear and tear?
Many riders experience cumulative tissue stress rather than single traumatic injuries. Autologous biologics are often explored for degenerative or overuse-related conditions, where long-term durability and recovery are critical.
How does this connect to the care of my horse or camel?
Our philosophy is holistic: • Vetinel® CellTech supports the animal using veterinary autologous biologics • Allegene Pharmalabs / ámvyx® supports the rider using human autologous biologics Both are built on the same GEN4™ principles of safety, sterility, and reproducibility—applied to different patients.
What is the ultimate goal for riders using these solutions?
Not short-term fixes, but sustainable performance.By supporting tissue health, recovery, and resilience—while ensuring the animal receives equivalent regenerative care—we aim to help rider and animal perform together, longer, and more safely.
Trainers
Why should a trainer care about regenerative medicine?
Modern regenerative therapies aim to support the body’s natural repair processes following injury or repetitive athletic stress. When incorporated into an appropriate veterinary treatment plan, they help horses return to training with healthier tissue and improved long-term soundness.
When should I suggest regenerative therapy to an owner?
If a horse develops tendon or ligament injuries, joint discomfort, slow-healing wounds, or recurring performance decline, discussing regenerative options with the attending veterinarian early may provide more treatment opportunities than waiting until the condition becomes chronic.
Does regenerative therapy replace rehabilitation?
Regenerative biologics are designed not to replace, but to complement veterinary treatment and structured rehabilitation or conditioning regimes.
Can these therapies help reduce time away from training?
Every horse heals differently, and recovery depends on the injury and rehabilitation program. Regenerative medicine aims to improve tissue quality and support functional recovery, helping veterinarians make evidence-based decisions for a quick return-to-performance.
Which horses benefit most?
Veterinarians commonly consider regenerative therapies for • Tendon and ligament injuries • Joint degeneration • Muscle injuries • Wounds and soft tissue damage • Performance-related wear and tear • Recovery after orthopedic procedures
How do Vetinel therapies fit into a trainer’s programme?
Vetinel offers both same-day point-of-care biologics and advanced laboratory cellular therapies. This gives veterinarians flexibility to select the most appropriate regenerative approach according to the horse’s condition, competitive schedule, and long-term goals.
Are these therapies suitable only for elite competition horses?
No. While many high-performance horses receive regenerative treatments, the same biologic principles may also benefit leisure horses, breeding animals, and working horses whenever tissue healing and functional recovery are priorities.
How can trainers work effectively with veterinarians using Vetinel therapies?
The best outcomes come from close collaboration between trainer, owner, and veterinarian. By monitoring performance, identifying problems early, following rehabilitation recommendations, and maintaining open communication, trainers play a crucial role in supporting successful regenerative treatment.
